N-Methyldeoxynojirimycin
CAS: 69567-10-8
Ref. 3D-MM04904
1mg | 156,00 € | ||
2mg | 195,00 € | ||
5mg | 325,00 € | ||
10mg | 506,00 € | ||
25mg | 1.013,00 € |
Produktinformation
- 1,5-Dideoxy-1,5-imino-1-methyl-D-sorbitolN-Me-DNJ
- (2R,3R,4R,5S)-2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol
- (2R,3R,4R,5S)-2-(hydroxymethyl)-1-methylpiperidine-3,4,5-triol
- 2-(Hydroxymethyl)-1-Methylpiperidine-3,4,5-Triol
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-methyl-, (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-methyl-, [2R-(2α,3β,4α,5β)]-
- Deoxynojirimycin, N-Methyl-
- Mor 14
- N-Methylmoranolin
- N-Methylmoranoline
- Mehr Synonyme anzeigen
N-Methyldeoxynojirimycin is a monoclonal antibody that is a competitive inhibitor of the melanoma antigen gp75. It is also an inhibitor of oligosaccharide synthesis and has been shown to have anti-inflammatory properties. N-Methyldeoxynojirimycin binds to the golgi alpha-mannosidases, preventing them from processing high-mannose type oligosaccharides. This leads to decreased chemoattractant protein production by neutrophils, which are important in the inflammatory process. N-Methyldeoxynojirimycin has also been shown to inhibit myocardial infarct size and glomerular filtration rate in rats, as well as increase biochemical markers for inflammation, such as α subunit of α1 acid glycoprotein and basic fibroblast growth factor.
Chemische Eigenschaften
Technische Anfrage zu: 3D-MM04904 N-Methyldeoxynojirimycin
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.